Leveraging the Undetectable = Untransmittable Campaign: Advocating for Improving Access and Engagement in Care
Resource (Conference Presentation) updated 09/14/2023
Resource (Conference Presentation) updated 09/14/2023
Resource (Conference Presentation) updated 09/14/2023
Resource (Conference Presentation) updated 09/14/2023
Rapid initiation of antiretroviral therapy (ART) after diagnosis can increase the number of patients arriving for appointments, shorten time to viral suppression, and promote health equity. The presenters share key lessons learned through the implementation process at a large HIV clinic in the South with the theme of partnerships.
Resource (Conference Presentation) updated 09/14/2023
In December 2016 CrescentCare began linking individuals newly diagnosed with within 72-hours through the CrescentCare START Initiative. We compared linkage and viral suppression between those under and over 24 years old. We found similar successful outcomes for both age cohorts in our intervention.
Resource (Conference Presentation) updated 09/14/2023
Implementation of rapid antiretroviral therapy (ART) initiation is beset with clinical and process challenges. Three clinical providers will share their lessons learned from developing a program and delivering care in various care settings (pediatric, adult, and walk-in clinic).
Resource (Conference Presentation) updated 09/14/2023
Resource (Conference Presentation) updated 12/11/2023
Rapid antiretroviral treatment (ART) initiation in the United States remained 'investigational' until the update in the Department of Health and Human Services guidelines (December 18, 2019). Centers for AIDS Research (CFARs) in D.C., the San Francisco Bay area, and Baltimore will share how they are working with their health departments and implementing partners, including Ryan White-funded clinics to address rapid ART implementation strategies.
Resource (Conference Presentation) updated 09/14/2023
Resource (Conference Presentation) updated 12/11/2023
Timely antiretroviral treatment (ART) initiation, linkage, and retention in care are critical keys for the optimal outcomes in patients with HIV infection. Implementing an open access process for medical, mental, and intensive case management care gives patients the ability to better achieve medication adherence and viral load suppression.
Resource (Conference Presentation) updated 09/14/2023
North Carolina's HIV/STD/Viral Hepatitis Unit, along with Western North Carolina Community Health Services and Carolina Family Health Center -- two federally qualified health centers (FQHCs) -- has initiated a pilot rapid antiretroviral treatment (ART) program utilizing carryover funds and a streamlined HIV Medication Assistance Program application process. Preliminary data will be shared on the success of the pilot program.
Resource (Conference Presentation) updated 09/14/2023
This presentation will review findings and lessons learned after implementing a pilot rapid antiretroviral therapy (ART) initiation protocol into an existing federally qualified health center (FQHC) setting. Presenters will describe the processes used for rapid linkage, benefits eligibility assessment, and provider appointment with ART initiation.
Resource (Conference Presentation) updated 09/14/2023
Prior analyses among transgender women receiving Ryan White Part A services in New York City have found evidence of disparities in HIV outcomes. This presentation will focus on viral suppression and the New York Eligible Metropolitan Area’s efforts to address care continuum outcome disparities affecting clients of transgender experience.
Resource (Conference Presentation) updated 09/14/2023
This session will focus on key findings and behavioral considerations for long-acting antiretroviral treatment (ART) HIV regimens, given the progress in research, development, and potential approval of these drugs. There will be a brief overview of the ATLAS and FLAIR studies, discussion of the medications, and an outline of the potential impact of the regimens on care delivery models, providers, patients, and payers if they are approved.
Resource (Conference Presentation) updated 09/14/2023
Preventing HIV with pre-exposure prophylaxis (PrEP) is a pillar of the Ending the HIV Epidemic initiative. This session will explore PrEP implementation resources for health centers developed by the National LGBT Health Education Center at The Fenway Institute and prepare participants to use and adapt them to their organizations.
Resource (Conference Presentation) updated 09/14/2023
Oklahoma has been classified by the Department of Health and Human Services as one of the seven states with a high rural HIV burden. Test-and-treat protocols are feasible within high-volume HIV clinics which serve rural and underserved communities to minimize the time to the first appointment to decrease time to viral load suppression.
Resource (Conference Presentation) updated 09/14/2023
Undetectable=Untransmittable: individuals who maintain viral suppression don't transmit HIV to their sexual partners. Yet some providers are uncomfortable discussing the implications of viral suppression in clinical encounters. This workshop will explore approaches to reduce provider discomfort in discussing U=U and present strategies to convey this message.
Resource (Conference Presentation) updated 09/14/2023
Transgender women, especially those of color, have substantially lower rates of viral suppression than people with HIV in general. The New York City HIV Planning Council collaborated with the community to develop guiding recommendations that drove the development of the jurisdiction's first psycho-social service directive specifically for people of transgender, intersex, non-binary, and/or non-conforming experience.
Resource (Conference Presentation) updated 09/14/2023
This workshop will explore the implementation of peer-led, evidence-informed interventions for transgender women with HIV. The programs are Healthy Divas, and Transgender Women Engagement and Entry to Care Project (T.W.E.E.T.). Attendees will learn the core elements of these interventions and how they improve engagement in care, treatment adherence, and viral suppression in Alabama and Michigan.
Resource (Conference Presentation) updated 09/14/2023
This presentation assesses social determinants that affect the HIV continuum of care. Establish patterns at the economic, demographic, and sociocultural factors that may fragment or, in a worst-case scenario, interrupt access to HIV testing, biomedical prevention, follow-up to a positive diagnosis, and adherence to treatment.
Resource (Conference Presentation) updated 09/14/2023